Lung Transplant Failure and Rejection Clinical Trial
Official title:
Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation
The use of Allosure to identify and quantify circulating donor-derived cell-free DNA to quantitate allograft injury in the early post-transplant period and determine its relationship to allograft failure.
Single Center Prospective Cohort Study on De-Novo Lung Transplant recipients. AlloSure will be drawn as part of routine blood draws and sent to CareDx for analysis of dd-cfDNA. All data will be collected and stored in the hospital EMR, this will be examined with the AlloSure results to correlate outcomes. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05050955 -
AlloSure Lung Assessment and Metagenomics Outcomes Study
|
||
| Terminated |
NCT04558333 -
CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation
|
||
| Recruiting |
NCT05006742 -
Comparison of Transbronchial Cryobiopsy and Forceps Biopsy in Lung Transplant Recipients
|
N/A | |
| Active, not recruiting |
NCT03656926 -
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)
|
Phase 3 | |
| Recruiting |
NCT04837339 -
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
|
N/A | |
| Enrolling by invitation |
NCT04787822 -
Long Term Follow up of the LTOG Cohort
|
||
| Enrolling by invitation |
NCT05934617 -
Trajectories of FEV1 After Lung Transplantation
|
||
| Active, not recruiting |
NCT04126746 -
Clinical Trials in Organ Transplantation Extension Study
|
||
| Active, not recruiting |
NCT03657342 -
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
|
Phase 3 |